Abbracchio Maria Pia

Characterisation of GPR17-expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses / S. Raffaele, B.H. Clausen, F.C. Mannella, M. Wirenfeldt, D. Marangon, S.B. Tidgen, S. Corradini, K. Madsen, D. Lecca, M.P. Abbracchio, K.L. Lambertsen, M. Fumagalli. - In: JOURNAL OF PATHOLOGY. - ISSN 0022-3417. - 265:2(2025 Feb), pp. 226-243. [10.1002/path.6381]

Neurodegeneration after brain ischemia in aged mice: beneficial effects of Montelukast / M. Muluhie, S. Raffaele, P. Gelosa, L. Castiglioni, B. Mercuriali, J. Rzemieniec, D. Lecca, M.P. Abbracchio, M. Fumagalli, L. Sironi. ((Intervento presentato al 42. convegno Science today for a better medicine tomorrow : Congresso Nazionale della Società Italiana di Farmacologia : 13 - 16 Novembre tenutosi a Sorrento nel 2024.

Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity / S. Raffaele, N. Nguyen, M. Milanese, F.C. Mannella, M. Boccazzi, G. Frumento, G. Bonanno, M.P. Abbracchio, T. Bonifacino, M. Fumagalli. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 1476-5381. - 181:18(2024 Sep), pp. 3303-3326. [10.1111/bph.16408]

G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation / M. Boccazzi, G. Macchiarulo, S. Lebon, J. Janowska, T. Le Charpentier, V. Faivre, J. Hua, D. Marangon, D. Lecca, M. Fumagalli, S. Mani, M.P. Abbracchio, P. Gressens, A. Schang, J. Van Steenwinckel. - In: NEUROBIOLOGY OF DISEASE. - ISSN 0969-9961. - 187:(2023 Oct 15), pp. 106315.1-106315.13. [10.1016/j.nbd.2023.106315]

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors / S.P.H. Alexander, A. Christopoulos, A.P. Davenport, E. Kelly, A.A. Mathie, J.A. Peters, E.L. Veale, J.F. Armstrong, E. Faccenda, S.D. Harding, J.A. Davies, M.P. Abbracchio, G. Abraham, A. Agoulnik, W. Alexander, K. Al‐hosaini, M. Bäck, J.G. Baker, N.M. Barnes, R. Bathgate, J. Beaulieu, A.G. Beck‐sickinger, M. Behrens, K.E. Bernstein, B. Bettler, N.J.M. Birdsall, V. Blaho, F. Boulay, C. Bousquet, H. Bräuner‐osborne, G. Burnstock, G. Caló, J.P. Castaño, K.J. Catt, S. Ceruti, P. Chazot, N. Chiang, B. Chini, J. Chun, A. Cianciulli, O. Civelli, L.H. Clapp, R. Couture, H.M. Cox, Z. Csaba, C. Dahlgren, G. Dent, S.D. Douglas, P. Dournaud, S. Eguchi, E. Escher, E.J. Filardo, T. Fong, M. Fumagalli, R.R. Gainetdinov, M.L. Garelja, M. de Gasparo, C. Gerard, M. Gershengorn, F. Gobeil, T.L. Goodfriend, C. Goudet, L. Grätz, K.J. Gregory, A.L. Gundlach, J. Hamann, J. Hanson, R.L. Hauger, D.L. Hay, A. Heinemann, D. Herr, M.D. Hollenberg, N.D. Holliday, M. Horiuchi, D. Hoyer, L. Hunyady, A. Husain, A.P. Ijzerman, T. Inagami, K.A. Jacobson, R.T. Jensen, R. Jockers, D. Jonnalagadda, S. Karnik, K. Kaupmann, J. Kemp, C. Kennedy, Y. Kihara, T. Kitazawa, P. Kozielewicz, H. Kreienkamp, J.P. Kukkonen, T. Langenhan, D. Larhammar, K. Leach, D. Lecca, J.D. Lee, S.E. Leeman, J. Leprince, X.X. Li, S.J. Lolait, A. Lupp, R. Macrae, J. Maguire, D. Malfacini, J. Mazella, C.A. Mcardle, S. Melmed, M.C. Michel, L.J. Miller, V. Mitolo, B. Mouillac, C.E. Müller, P.M. Murphy, J. Nahon, T. Ngo, X. Norel, D. Nyimanu, A. O’Carroll, S. Offermanns, M.A. Panaro, M. Parmentier, R.G. Pertwee, J. Pin, E.R. Prossnitz, M. Quinn, R. Ramachandran, M. Ray, R.K. Reinscheid, P. Rondard, G.E. Rovati, C. Ruzza, G.J. Sanger, T. Schöneberg, G. Schulte, S. Schulz, D.L. Segaloff, C.N. Serhan, K.D. Singh, C.M. Smith, L.A. Stoddart, Y. Sugimoto, R. Summers, V.P. Tan, D. Thal, W.(.W. Thomas, P.B.M.W.M. Timmermans, K. Tirupula, L. Toll, G. Tulipano, H. Unal, T. Unger, C. Valant, P. Vanderheyden, D. Vaudry, H. Vaudry, J. Vilardaga, C.S. Walker, J.M. Wang, D.T. Ward, H. Wester, G.B. Willars, T.L. Williams, T.M. Woodruff, C. Yao, R.D. Ye. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - 180:S2 (special issue)(2023 Oct), pp. 23-144. [10.1111/bph.16177]